Affiliation:
1. National Pirogov Memorial Medical University, Vinnytsia, Ukraine
Abstract
Objective: to study endometrium state in women with recurrent miscarriage and chronic endometritis by determining of nuclear cyclin E and syndecan-1, followed by a study of the effectiveness of proposed scheme for managing pregnancy in this category of patients.Materials and methods. Endometrium state (in particular its immunohistochemical characteristics) was studied by determining syndecan-1 in endometrial samples during hysteroscopy or pipelle biopsy in 68 women (main group) with recurrent miscarriage, followed by an analysis of the effectiveness of the proposed schemes of pregravid preparation. The women of the main group were divided into: subgroup 1 (40 pregnant women), whose treatment regimen included antibiotic therapy, folates and micronized progesterone at the pregravid stage; subgroup 2 (28 participants), whose treatment regimen included antibacterial drugs, folate at the pregravid stage and micronized progesterone from early gestation.The control group consisted of 30 re-pregnant women without a history of reproductive losses.Results. Features of the endometrium state in women with recurrent miscarriage are characterized by the presence of the CD138 protein (syndecan-1) and an abnormal (elevated) level of nuclear cyclin E, which indicates a morphological reorganization of the endometrial layer and its unpreparedness for successful implantation and further gestation. This study proved successful correction of the endometrium state at the stage of preconception preparation due to the use of micronized progesterone Utrogestan®, which consisted in reducing the percentage of reproductive losses, improving the course of pregnancy and childbirth.Conclusions. Utrogestan is a reliable, safe and effective treatment for women with recurrent miscarriage against the background of chronic endometritis even at the stage of preconception preparation. Such regimen allows transforming the endometrium and preparing it for implantation, thereby significantly improving the microenvironment for the early embryo development and successful pregnancy.
Publisher
Publishing Office TRILIST
Subject
Obstetrics and Gynecology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism
Reference35 articles.
1. Definitions of infertility and recurrent pregnancy loss: a committee opinion;Practice;Fertility and Sterility,2020
2. ESHRE Early Pregnancy Guideline Development Group. Guideline on the Management of Recurrent Pregnancy Loss. Version 2. ESHRE Grimbergen, Belgium (2017).
3. Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG: London, UK (2011).
4. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050);Toth;Geburtshilfe und Frauenheilkunde,2018
5. Ministry of Health of Ukraine. Order from 03.11.2008 № 624 “On approval of clinical protocols for obstetric and gynecological care”.